Suppr超能文献

糖尿病诱导人内皮细胞中y+系统和一氧化氮合酶的激活:与膜超极化的关联。

Diabetes-induced activation of system y+ and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization.

作者信息

Sobrevia L, Cesare P, Yudilevich D L, Mann G E

机构信息

Vascular Biology Research Centre, King's College London, UK.

出版信息

J Physiol. 1995 Nov 15;489 ( Pt 1)(Pt 1):183-92. doi: 10.1113/jphysiol.1995.sp021040.

Abstract
  1. The activity of the human endothelial cell L-arginine transporter (system y+) has been correlated with cGMP production (index of nitric oxide) and prostacyclin (PGI2) release in umbilical vein endothelial cells cultured from normal or gestational diabetic pregnancies. 2. In non-diabetic and diabetic cells, transport of L-arginine was Na+ and pH independent, inhibited by other cationic L-arginine analogues and unaffected by neutral amino acids. 3. Diabetes was associated with an increased Vmax for saturable L-arginine transport (4.6 +/- 0.13 vs. 9.9 +/- 0.5 pmol (microgram protein)-1 min-1, P < 0.01), but had no effect on initial rates of transport for L-serine, L-citrulline, L-leucine or 2-deoxyglucose. 4. In non-diabetic and diabetic cells, elevated K+ resulted in a concentration-dependent inhibition in the initial rates of transport for L-arginine and the membrane potential-sensitive probe tetra[3H]phenylphosphonium (TPP+). 5. When resting membrane potential was measured using the whole-cell patch voltage clamp technique, diabetic cells were hyperpolarized (-78 +/- 0.3 mV) compared with non-diabetic cells (-70 +/- 0.04 mV, P < 0.04). Accumulation of [3H]TPP+ was also increased in diabetic compared with non-diabetic cells. 6. Basal intracellular cGMP levels were elevated 2.5-fold in diabetic cells, and L-NAME (100 microM), an inhibitor of nitric oxide synthase, abolished basal cGMP accumulation in non-diabetic and diabetic cells. 7. Histamine (10 microM) had no effect on L-arginine transport but evoked significant increases in cGMP in non-diabetic and diabetic cells, which were completely inhibited by L-NAME but unaffected by superoxide dismutase. 8. Basal and histamine-stimulated PGI2 release was decreased markedly in diabetic cells. 9. Our findings demonstrate that gestational diabetes is associated with phenotypic changes in fetal endothelial cells, which result in a membrane hyperpolarization, activation of the human endothelial cell L-arginine transporter (system y+), elevation of basal nitric oxide synthesis and decreased PGI2 production.
摘要
  1. 人内皮细胞L-精氨酸转运体(系统y+)的活性与从正常或妊娠糖尿病孕妇培养的脐静脉内皮细胞中环鸟苷酸(一氧化氮指标)的产生以及前列环素(PGI2)的释放相关。2. 在非糖尿病和糖尿病细胞中,L-精氨酸的转运不依赖于Na+和pH,受其他阳离子L-精氨酸类似物抑制,不受中性氨基酸影响。3. 糖尿病与可饱和L-精氨酸转运的Vmax增加有关(4.6±0.13对9.9±0.5 pmol(微克蛋白)-1分钟-1,P<0.01),但对L-丝氨酸、L-瓜氨酸、L-亮氨酸或2-脱氧葡萄糖的初始转运速率没有影响。4. 在非糖尿病和糖尿病细胞中,细胞外K+升高导致L-精氨酸和膜电位敏感探针四[3H]苯基鏻(TPP+)的初始转运速率呈浓度依赖性抑制。5. 当使用全细胞膜片钳技术测量静息膜电位时,与非糖尿病细胞(-70±0.04 mV,P<0.04)相比,糖尿病细胞发生超极化(-78±0.3 mV)。与非糖尿病细胞相比,糖尿病细胞中[3H]TPP+的积累也增加。6. 糖尿病细胞中基础细胞内cGMP水平升高2.5倍,一氧化氮合酶抑制剂L-NAME(100 microM)消除了非糖尿病和糖尿病细胞中的基础cGMP积累。7. 组胺(10 microM)对L-精氨酸转运没有影响,但在非糖尿病和糖尿病细胞中引起cGMP显著增加,这被L-NAME完全抑制,但不受超氧化物歧化酶影响。8. 糖尿病细胞中基础和组胺刺激的PGI2释放明显减少。9. 我们的研究结果表明,妊娠糖尿病与胎儿内皮细胞的表型变化有关,这导致膜超极化、人内皮细胞L-精氨酸转运体(系统y+)激活、基础一氧化氮合成增加和PGI2产生减少。

相似文献

引用本文的文献

9
The placenta and gestational diabetes mellitus.胎盘与妊娠糖尿病。
Curr Diab Rep. 2012 Feb;12(1):16-23. doi: 10.1007/s11892-011-0244-5.

本文引用的文献

1
Weight and length at birth of infants of diabetic mothers.糖尿病母亲所生婴儿的出生体重与身长
Acta Endocrinol (Copenh). 1954 Aug;16(4):330-42. doi: 10.1530/acta.0.0160330.
4
Gestational diabetes: a challenge for the future.
Diabet Med. 1993 Dec;10(10):897-905. doi: 10.1111/j.1464-5491.1993.tb00004.x.
7
Characterization of amino acid transport in human endothelial cells.人内皮细胞中氨基酸转运的特征分析
Am J Physiol. 1993 Oct;265(4 Pt 1):C1006-14. doi: 10.1152/ajpcell.1993.265.4.C1006.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验